Treatment

GLP-1 clinical trials

Active studies that list GLP-1 as an intervention or treatment.

3active studies

2recruiting now

2countries represented

1largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowNot applicable

Multiple SclerosisCondition

GLP-1, Ocrelizumab (US)Treatment

United States1 locations

Northwestern UniversitySponsor

Updated 2026-03-17 · NCT07207148See eligibility →

Recruiting nowNot applicable

Binge Eating Disorder Associated With Obesity, Binge Eating DisorderCondition

GLP-1, CBTe Group TherapyTreatment

Norway1 locations

Haukeland University HospitalSponsor

Updated 2025-09-15 · NCT07042672See eligibility →

Invitation onlyEarly Phase 1

Longevity, Quality of LifeCondition

GLP-1, PlaceboTreatment

United States1 locations

AgelessRxSponsor

Updated 2025-07-30 · NCT07092605See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.